Press Releases

Emergent Biosolutions to Hold Annual Meeting of Stockholders Thursday May 19, 2016 at 9:00 AM Eastern; Webcast Will Be Available

...

Read More

Emergent Biosolutions to Participate in the Bank of America Merrill Lynch Healthcare Conference in May 2016

...

Read More

Emergent BioSolutions to Release First Quarter 2016 Financial Results and Conduct a Conference Call on May 5, 2016

...

Read More

Emergent BioSolutions Presents Preclinical Data on ES425 a Bispecific Immunotherapeutic Protein for Triple-Negative Breast Cancer

...

Read More

Emergent BioSolutions Submits sBLA for FDA Approval of Large-Scale Manufacturing of BioThrax in Building 55

...

Read More

Emergent BioSolutions Announces Filing of Form 10 Registration Statement for Its Planned Spin-Off of Its Biosciences Business Aptevo Therapeutics

...

Read More

Emergent BioSolutions to Participate in Needham & Company’s 15th Annual Healthcare Conference in April 2016

...

Read More

Emergent BioSolutions Reports Fourth Quarter and Twelve Months 2015 Financial Results and Reaffirms 2016 Outlook

...

Read More

Emergent BioSolutions’ Emergard Auto-Injector Platform for Nerve Agent Antidote Delivery Selected by U.S. Department of Defense and Battelle for Testing and Development

...

Read More

Emergent BioSolutions to Release Fourth Quarter and Full Year 2015 Financial Results and Conduct a Conference Call on February 25, 2016

...

Read More

Emergent BioSolutions Announces Executive Management Team of New Spin-Off Company Aptevo Therapeutics

...

Read More

Emergent BioSolutions Announces Preliminary 2015 Financial Results, Provides 2016 Financial Outlook, and Outlines New Five-Year (2016-2020) Strategic Growth Plan

...

Read More